39 results on '"Tatsugami, Katsunori"'
Search Results
2. Reality of nerve sparing and surgical margins in surgeons’ early experience with robot‐assisted radical prostatectomy in Japan
3. Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5α-Reductase Inhibitor
4. Antitumor activity of recombinant Bacille Calmette-Guérin secreting interleukin-15-Ag85B fusion protein against bladder cancer
5. CROSSTALK BETWEEN EPITHELIAL-MESENCHYMAL TRANSITION AND CASTRATION RESISTANCE IN PROSTATE CANCER: MP62-20
6. CLINICAL OUTCOMES IN PATIENTS WITH METASTATIC PAPILLARY RENAL CELL CARCINOMA: A JAPANESE MULTI-INSTITUTIONAL STUDY: MP03-13
7. Role of cytoreductive nephrectomy for Japanese patients with primary renal cell carcinoma in the cytokine and targeted therapy era
8. Prognosis of Japanese patients with previously untreated metastatic renal cell carcinoma in the era of molecular-targeted therapy
9. MP69-19 EXTENDED ANALYSES OF PHASE II CLINICAL TRIAL OF SORAFENIB PLUS INTERFERON-ALPHA TREATMENT FOR PATIENTS WITH METASTATIC RENAL CELL CARCINOMA IN JAPAN
10. MP46-11 TARGETING RIBOSOMAL S6 KINASES/Y-BOX BINDING PROTEIN-1 SIGNALING IMPROVES CELLULAR SENSITIVITY TO TAXANE IN PROSTATE CANCER
11. Pathological manifestation of difference in washout pattern of adrenal hyperplasia on dynamic CT
12. The feature of metabolic syndrome is a risk factor for biochemical recurrence after radical prostatectomy
13. The Oncological Outcomes and Risk Stratification in Docetaxel Chemotherapy for Castration-resistant Prostate Cancer
14. Inhibition of RSK/YB-1 signaling enhances the anti-cancer effect of enzalutamide in prostate cancer
15. Targeting ribosomal S6 kinases/Y-box binding protein-1 signaling improves cellular sensitivity to taxane in prostate cancer
16. INTERACTION BETWEEN DOCETAXEL RESISTANCE AND CASTRATION RESISTANCE IN PROSTATE CANCER: IMPLICATIONS OF TWIST1, YB-1 AND ANDROGEN RECEPTOR: MP24-06
17. Final Results of a Phase II Study of S-1 in Patients with Cytokine-refractory Metastatic Renal Cell Carcinoma
18. Interaction between docetaxel resistance and castration resistance in prostate cancer: Implications of Twist1, YB-1, and androgen receptor
19. HIGH PREOPERATIVE PLASMA EPINEPHRINE LEVEL IS A RISK FACTOR FOR INTRA OPERATIVE HYPERTENSION DURING LAPAROSCOPIC ADRENALECTOMY FOR PHEOCHROMOCYTOMA: 43
20. Causes of diminished renal function in the affected kidney after partial nephrectomy
21. A new prognostic classification for overall survival in Asian patients with previously untreated metastatic renal cell carcinoma
22. Methyltransferase Inhibitor Adenosine Dialdehyde Suppresses Androgen Receptor Expression and Prostate Cancer Growth
23. Androgen Receptor Signaling Regulates Cell Growth and Vulnerability to Doxorubicin in Bladder Cancer
24. Antioxidant Therapy Alleviates Oxidative Stress by Androgen Deprivation and Prevents Conversion From Androgen Dependent to Castration Resistant Prostate Cancer
25. A reduction of recipient regulatory T cells by cyclophosphamide contributes to an anti-tumor effect of nonmyeloablative allogeneic stem cell transplantation in mice
26. Statins reduce the androgen sensitivity and cell proliferation by decreasing the androgen receptor protein in prostate cancer cells
27. Mechanism of Synergistic Antitumor Effect of Sorafenib and Interferon-α on Treatment of Renal Cell Carcinoma
28. P300/CBP-associated factor regulates Y-box binding protein-1 expression and promotes cancer cell growth, cancer invasion and drug resistance
29. Transurethral endoscopic treatment of patients with upper tract urothelial carcinomas using neodymium-YAG and/or holmium-YAG laser ablation
30. Foxo3a expression and acetylation regulate cancer cell growth and sensitivity to cisplatin
31. Peroxisome Proliferator-Activated Receptor γ Coactivator-1α Interacts with the Androgen Receptor (AR) and Promotes Prostate Cancer Cell Growth by Activating the AR
32. Allogeneic cell therapy from immunized donors with tumor antigen peptide enhances the antitumor effect after cyclophosphamide-using non-myeloablative allogeneic hematopoietic cell transplantation
33. Dendritic cell therapy in combination with interferon-α for the treatment of metastatic renal cell carcinoma
34. The efficacy of laparoscopic radical nephrectomy for renal cell cancer in the elderly: An oncological outcome analysis
35. VACCINATION OF DONORS WITH TUMOR ANTIGEN PEPTIDE ENHANCES THE ANTITUMOR EFFECT ON RENAL TUMORS IN RECIPIENT MICE WITH NONMYELOABLATIVE ALLOGENEIC HEMOPOIETIC CELL TRANSPLANTATION: 105
36. Laparoscopic adrenalectomy for malignant tumors
37. Inositol 1,4,5-trisphosphate (IP3) receptor type1 (IP3R1) modulates the acquisition of cisplatin resistance in bladder cancer cell lines
38. Anti-tumour activity of heat-shock protein 60-recognizing CD4+ T cells against syngeneic murine renal cell carcinoma
39. Evidence of the extrathymic development of tyrosinase-related protein-2-recognizing CD8+ T cells with low avidity
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.